Glycaemic Efficacy And Safety Of Ertugliflozin In Patients With Type 2 Diabetes And Stage 3 Chronic Kidney Disease: An Analysis From Vertis Cv
DIABETOLOGIA（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined